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We show that Escherichia coli isolates originating from 
Arctic birds carry antimicrobial drug resistance determi-
nants. This ﬁ  nding implies that dissemination of drug-resis-
tant bacteria is worldwide. Resistance genes can be found 
even in a region where no selection pressure for resistance 
development exists. 
B
acteria display a unique ability to adapt to changes 
in their environment and to develop mechanisms to 
protect themselves against toxic compounds. Their ability 
to develop resistance mechanisms to antimicrobial drugs 
has assumed catastrophic proportions, rendering more and 
more infections difﬁ  cult or impossible to treat (1). Most 
reports suggest that the main force behind emergence of 
drug resistance is the use and misuse of antimicrobial drugs 
during the past few decades, but there is also evidence for 
the epidemic spread of drug-resistant bacteria as a contrib-
uting factor (2).
The Study
We investigated bacteria from a region considered to 
be one of the last outposts of wilderness, the Arctic, with 
the belief that in this region human inﬂ  uence on the ecol-
ogy of antimicrobial resistance would be minimal. Antimi-
crobial drug resistance in Escherichia coli isolated on site 
from fecal or cloacal swabs of Arctic birds was studied.
During the Beringia expedition organized by the 
Swedish Polar Research Secretariat in 2005, fecal or cloa-
cal samples were collected from 97 birds in 3 geographic 
regions: northeastern Siberia; Point Barrow, Alaska, USA 
(71º30′N, 156º78′W); and northern Greenland. Samples 
were transported in a swab-transport system to a laboratory 
on the expedition ship. Upon arrival, the samples were im-
mediately cultured, and single colonies of enterobacteria 
were isolated on blood agar plates (3). One isolate of E. coli 
was selected from each sample and stored at –70°C for fur-
ther analysis. Susceptibility to 17 antimicrobial drugs was 
determined by using disk diffusion with disks on Iso-Sens-
itest agar (Oxoid, Basingstoke, UK) in accordance with the 
recommendations of the Swedish Reference Group for An-
tibiotics (4). MIC determinations were performed by using 
the E-test (AB Biodisk, Solna, Sweden) on Iso-Sensitest 
agar. All bacteria were tested against the following anti-
microbial drugs: ampicillin, cefadroxil, cefuroxime, ce-
fpodoxime (to screen for E. coli with extended-spectrum 
β-lactamases), chloramphenicol, ciproﬂ  oxacin,  fosfomy-
cin-trometamol, gentamicin, imipenem, mecillinam, nali-
dixic acid, nitrofurantoin, streptomycin, sulfamethoxazole, 
tetracycline, trimethoprim, and tigecycline.
Clonal diversity of the 97 isolates was assessed by us-
ing a commercial typing system, the PhenePlate (PhP) sys-
tem (PhPlate Microplate Techniques AB, Stockholm, Swe-
den). This system uses results of 11 biochemical reactions 
in a microplate to obtain a biochemical ﬁ  ngerprint of each 
tested isolate and has been used for typing of E. coli (5,6). 
Compared with traditional qualitative biochemical testing 
where the results are read once, PhP typing is based on sev-
eral readings and thereby includes dynamics of the reac-
tion in the analysis. PhP typing was performed as described 
with 2 modiﬁ  cations: 1 of the 11 reagents, melabionate, 
was replaced with rafﬁ  nose, and E. coli reference strain 
ATCC 25922 was used as a positive control (6). Biochemi-
cal ﬁ  ngerprints obtained were compared with each other, 
and similarity was calculated by using PhPWIN4 software 
(6). PhP types with >2 isolates with the same biochemical 
ﬁ  ngerprint were designated as common types (CTs); types 
with 1 isolate, which represented rare or unique clones, 
were designated as single (Si) types.
E. coli isolates from Arctic birds carried antimicro-
bial drug resistance determinants; among 17 antimicrobial 
drugs tested, resistance to 14 was detected. Resistance was 
observed in 8 isolates, 4 of which displayed resistance to 
>4 drugs (Table), and occurred most often to ampicillin, 
sulfamethoxazole, trimethoprim, chloramphenicol, and tet-
racycline. Two resistant isolates displayed isolated fosfo-
mycin resistance with MIC values of 256 mg/L and 1,024 
mg/L. No resistance to gentamicin, imipenem, or tigecy-
cline was observed.
PhP typing divided the 97 isolates into 11 CTs (CT1–
CT11) and 34 Si types (online Appendix Table, available 
from www.cdc.goc/EID/content/14/1/70-appT.htm). The 
3 most frequent CTs were CT3, CT2, and CT5, which 
contained 29, 9, and 5 isolates, respectively. Among the 
isolates from Lorino, Siberia (65º39′N, 172º15′W), (n = 
13), Si types were most common (n = 5). Likewise, among 
isolates from Novo Chaplino, Siberia (64º70′N, 173º00′W) 
(n = 33), Si types (n = 19) predominated. In contrast, only 
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2 Si types were found among isolates from Kolyuchin, 
Siberia (67º04′N, 173º21′W) (n = 29). Most of these iso-
lates (n = 18) were deﬁ  ned as CT3. Six of the 11 CTs were 
restricted to 1 sample site: CT1 at Lorino, CT6 at Novo 
Chaplino, CT7 at Kolyuchin, CT9 and CT10 at Wrangel 
Island (70º55′N, 179º29′W), and CT11 at Thule, Greenland 
(76º32′N, 68º44′W). Among the 8 drug-resistant isolates, 
1 was CT3 and 2 were CT5; the other 5 were deﬁ  ned as Si 
types (Table).
Conclusions
Antimicrobial drug resistance in E. coli isolated from 
wild birds has been described (7,8). A high frequency of 
E. coli isolates from migratory Canada geese sampled on 
the eastern shore of Maryland in the United States were 
resistant to penicillin G, ampicillin, cephalothin, and sulfa-
thiazole (8). Similarly, a high prevalence of antimicrobial 
drug–resistant E. coli isolated from black-headed gulls in 
the Czech Republic has been observed (7).
There are several explanations for antimicrobial drug 
resistance in the normal microbiota of Arctic birds. First, 
resistance may develop de novo through spontaneous 
mutation(s) (9). Second, resistance can be acquired by hor-
izontal gene transfer from other microbes; many bacteria 
and fungi constitute natural sources of drug resistance genes 
and may serve as reservoirs in the environment (10). Third, 
bacteria with antimicrobial drug resistance could be im-
ported into the region either by migratory birds or through 
human refuse (food, excretions) from ﬁ  shermen, settlers, 
and prospectors in the area. The region around the Bering 
Strait constitutes the breeding ground of a large number of 
waterfowl, geese, and shorebirds. Although many of these 
species are largely conﬁ  ned to one side of the Bering Strait, 
other species pass through both continents during migra-
tion or occasionally wander across the strait (11). More-
over, bird species that spend the winter in up to 6 different 
continents can be found in this area (11). Thus, migratory 
birds that have acquired drug-resistant bacteria during win-
tering or stops at lower latitudes before migrating to the 
Arctic provide a potential explanation for introduction of 
drug resistance into this region. The fact that 1 isolate from 
a juvenile Western sandpiper sampled far from human set-
tlements on the tundra had  resistance to cefadroxil, cefu-
roxime, and cefpodoxime, a resistance pattern commonly 
seen in clinical isolates, supports the theory of introduction 
by migration and transfer of bacteria between birds.
To the best of our knowledge, the most remote and iso-
lated environment investigated for drug-resistant bacteria 
is the Bolivian community of 130 Guaraní Indians, as de-
scribed by Bartoloni et al. (12). This community is located 
at an altitude of ≈1,700 m and can only be reached by a 3-
hour steep climb. Nevertheless, high carriage rates of drug-
resistant commensal E. coli were found in this community, 
although exposure to antimicrobial drugs in the area had 
been limited. Similarly, antimicrobial drug–resistant bacte-
ria in wild animals with little or no contact with human set-
tings has been reported (13,14). These ﬁ  ndings and those of 
our study suggest that commensal bacteria in humans and 
animals constitute hidden reservoirs of antimicrobial drug 
resistance (15). A possible explanation for the unexpect-
edly high carriage rate of drug-resistant E. coli in the Indian 
community in Bolivia is the importation of drug-resistant 
isolates by migratory birds.
We have shown that antimicrobial drug resistance 
genes are present in 1 of the most remote areas on Earth, 
the Arctic. Resistant as well as multiresistant isolates of E. 
coli were detected in the normal ﬂ  ora of Arctic birds. This 
ﬁ  nding highlights the unique nature of bacterial adaptation 
and the complexity of dissemination of antimicrobial drug 
resistance. To fully understand the extent of environmental 
and commensal reservoirs of resistance, studies of antimi-
crobial drug resistance in different habitats are warranted. 
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Table. Antimicrobial drug resistance phenotypes in 8 Escherichia coli isolates from Arctic birds 
Isolate Avian host species Geographic origin PhenePlate type* Drug resistance profile†
2 Western sandpiper Lorino, Siberia Si Amp, Cpd, Cdr, Cxm
18 Vega/Glaucous gull Novo Chaplino, Siberia CT3 Amp, Cpd
26 Vega/Glaucous gull Novo Chaplino, Siberia Si Amp, Sul, Chl, Tet, Tri, Nit, Str
35 Vega/Glaucous gull Novo Chaplino, Siberia Si Fos
36 Vega/Glaucous gull Novo Chaplino, Siberia Si Fos
75 Emperor/Brent goose Kolyuchin, Siberia CT5 Tet
94 Iceland/Glaucous gull Thule, Greenland CT5 Amp, Sul, Chl,Mec, Tet, Tri, Str
97 Iceland/Glaucous gull Thule, Greenland Si Amp, Sul, Chl, Mec, Tri, Str, Nal, Cip
*Si, single type; CT, common type. 
†Amp, ampicillin; Cpd, cefpodoxime; Cdr, cefadroxil; Cxm, cefuroxime; Sul, sulfamethoxazole; Chl, chloramphenicol; Tet, tetracycline; Tri, trimethoprim; 
Nit, nitrofurantoin; Str, streptomycin; Fos, fosfomycin; Mec, mecillinam; Nal, nalidixic acid; Cip, ciprofloxacin. characterization of drug-resistant bacteria, mechanisms of resis-
tance, and studies of the biological cost of drug resistance.
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